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Background: Vitamin D may play a pivotal role in regulating insulin secretion and insulin 
sensitivity. However, the impact of vitamin D intake either from diet or from supplements on the 
development of gestational diabetes mellitus (GDM) remains unknown. We prospectively 
examined the association of pre-pregnancy habitual intake of vitamin D from diet and 
supplements with risk of incident GDM in a well-established cohort.  
Methods: We included 21,356 singleton pregnancies from 15,225 women in the Nurses' Health 
Study II cohort. Diet information, including vitamin D intakes from food sources and 
supplements, was assessed in 1991 and every four years thereafter by validated food frequency 












questionnaires. We used log-binomial models with generalized estimating equations to estimate 
the relative risks (RRs) and 95% confidence intervals (CIs).  
Results: We documented 865 incident GDM cases during 10 years of follow-up. After 
adjustment for age, parity, race/ethnicity, family history of diabetes, dietary and lifestyle factors, 
and body mass index, the RRs (95% CIs) of GDM risk associated with supplemental vitamin D 
intake of 0, 1-399, ≥ 400 IU/d were 1.00 (reference), 0.80 (0.67-0.96), and 0.71 (0.56-0.90), 
respectively (P for trend = 0.002). Dietary and total vitamin D intakes were also inversely 
associated with GDM risk, but the associations were not statistically significant.  
Conclusions: Pre-pregnancy supplemental vitamin D intake was significantly and inversely 
associated with risk of GDM. Our study indicates potential benefits of increasing vitamin D 
intake from supplements in the prevention of GDM in women of reproductive age. 
 
  













• Vitamin D insufficiency is common in pregnant women, and it has been associated with 
gestational diabetes. However, the impact of vitamin D intake either from diet or from 
supplements on the development of gestational diabetes mellitus (GDM) remains unknown.  
• In a large prospective cohort study, we found that pre-pregnancy supplemental vitamin D 
intake was significantly and inversely associated with risk of GDM. These results indicate 
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Gestational diabetes mellitus (GDM), characterized by glucose intolerance with onset or 
first recognition during pregnancy, is a common pregnancy complication that affects 
approximately 9% of all pregnancies.1 GDM is not only associated with adverse pregnancy and 
perinatal outcomes, but also related to an increased risk of long-term adverse health outcomes for 
both mother and child in later life, including type 2 diabetes, metabolic syndrome, and 
cardiovascular disease.2 For example, women with a history of GDM have more than 7-fold 
increased risk of developing type 2 diabetes.3 Thus, it is crucial to identify important modifiable 
risk factors that could prevent the development of GDM. 
Vitamin D insufficiency is widespread around the world across various age groups.4 In 
the United States, the prevalence of vitamin D insufficiency, defined as 25-hydroxyvitamin D 
(25[OH]D) level < 75 nmol/L, is 83% among pregnant women in the first trimester.5 Moreover, 
78% of non-pregnant women of childbearing age have vitamin D insufficiency.5 These data 
indicate that a substantial number of women may enter pregnancy with suboptimal vitamin D 
status. 
Evidence from previous studies in animals and humans suggests that vitamin D may play 
a pivotal role in regulating insulin secretion6-8 and insulin sensitivity.6 9 In addition, improved 
vitamin D status by vitamin D supplementation could normalize fasting glucose levels and 
attenuate insulin resistance in pregnant women.10-12 Some, although not all, previous studies 
found that maternal low concentration of 25(OH)D during early pregnancy was associated with 
increased risk of GDM.13 14 Interestingly, a recent animal study has shown that high vitamin D 
status before pregnancy, but not during pregnancy, is inversely associated with the development 
of GDM.15 However, the impact of vitamin D intake either from diet or from supplements on the 












development of GDM has not been investigated. Using data from a well-established prospective 




The Nurses’ Health Study II (NHSII) is a prospective cohort study established in 1989, 
with 116,430 female nurses aged 24-44 years at study inception. The participants reported 
information regarding disease outcomes and lifestyle behaviors, such as smoking status and 
medication use on a biennial questionnaire. Follow-up for each questionnaire cycle was greater 
than 90%. This study has been approved by the Partners Human Research Committee (Boston, 
MA, USA), with participants’ consent implied by the return of the questionnaires by mail. 
We included NHSII participants in this analysis if they had at least one singleton 
pregnancy lasting longer than 6 months between 1991 and 2001. The 2001 questionnaire was the 
last time questions regarding GDM were included, as the majority of NHSII participants had 
passed reproductive age by then. Pregnancies became eligible if there was no prior GDM, or a 
prior diagnosis of T2DM, cardiovascular disease, or cancer. We excluded individuals who had 
missing information on vitamin D intake at baseline. Women with GDM in a previous pregnancy 
were not included because they may change their diet and lifestyle during the next pregnancy to 
prevent recurrent GDM. 
Exposure Assessment 
Intakes of dietary vitamin D, other nutrients, and alcohol were assessed in 1991 and every 
4 years thereafter using an extensively validated food frequency questionnaire.16-19 Information 
on current use and doses of specific vitamin D supplements and vitamin D-containing 












multivitamins was collected biennially. Total vitamin D intake was calculated as the sum of 
dietary and supplemental vitamin D intakes from all sources.  
Covariate Assessment 
Data on age, race/ethnicity, residence, anthropometric measures, physical activity, and 
dietary intake, were collected using standardized questionnaires. Height and weight were 
reported in 1989 and weight was updated every two years. Self-reported body weight was highly 
correlated (r = 0.97) with technician-measured weight in a previous validation study.20 Body 
mass index (BMI) was computed as weight in kilograms divided by height in meters squared. 
Physical activity was assessed by frequency of engaging in common recreational activities in 
1991 and 1997. Total physical activity was calculated as metabolic equivalent task (MET)-hours 
per week. In a previous validation study, the questionnaire-based estimates of physical activity 
correlated well (r = 0.56) with detailed activity diaries.21 We calculated the Alternate Healthy 
Eating Index 2010 (AHEI) as previously described22 to represent overall diet quality. Previous 
studies have linked higher AHEI score, indicating a better diet quality, to a lower risk of major 
chronic diseases.22 Race/ethnicity (Caucasians, African-American, Hispanic, Asian, others) was 
reported in 1989. Besides dietary and supplemental vitamin D intake, solar ultraviolet-B (UVB) 
radiation is considered a key source of circulating 25(OH)D, because UVB stimulates the 
conversion from 7-dehydrocholesterol to vitamin D3 in the epidermis of the skin. Average 
annual UVB flux, a composite measure of mean UVB radiation level on the earth’s surface 
taking into account factors such as latitude, altitude and cloud cover, was approximated based on 
state of residence (i.e., mailing address) on each of the questionnaires.23  
Outcome Ascertainment 












On each of the biennial questionnaires from 1991 to 2001, the NHSII participants 
reported incident GDM as diagnosed by a physician. In the case of more than one pregnancy 
lasting longer than 6 months reported within a 2-year questionnaire period, GDM status was 
attributed to the first pregnancy. Self-reports on GDM diagnosis has been previously validated 
among a subgroup of in the NHSII cohort, with 94% of GDM self-reports confirmed by medical 
records.24 In a random sample of parous women without GDM, a high level of GDM 
surveillance was observed, with 83% reporting a glucose screening test during pregnancy and 
100% reporting frequent prenatal urine screenings during pregnancy.24 During the period that 
GDM events were reported in the present study (1991-2001), the National Diabetes Data Group 
criteria25 have been widely adopted for GDM diagnosis. 
Statistical Analysis 
We used log-binomial models26 with generalized estimating equations (GEE) to estimate 
relative risks (RRs) and 95% confidence intervals (CIs). The GEE method allows us to account 
for correlations among repeated observations (pregnancies) contributed by a single participant.27 
We calculated the updated cumulative average vitamin D intake for each individual at each time 
period, in order to represent long-term usual vitamin D intake and reduce within-subject 
variation.28 
For vitamin D intake, we fit multivariable models adjusting for age, parity, race/ethnicity, 
family history of diabetes, cigarette smoking, alcohol intake, physical activity, estimated UVB 
flux, BMI, total energy intake, and intakes of saturated fat, monounsaturated fat, polyunsaturated 
fat, trans fat, dietary cholesterol, glycemic load, dietary fiber, magnesium, calcium, and vitamin 
A. All of these variables were updated throughout the follow up, except family history of 












diabetes and race/ethnicity that was reported in 1989. To test for a significant trend across 
quartiles, we modeled median values of each category as a continuous variable. 
To evaluate effect modification, we conducted stratified analyses according to age (< 35 
vs. ≥ 35 years), family history of diabetes (yes vs. no), overall diet quality (AHEI dietary pattern 
score < median vs. ≥ median), physical activity (< median vs. ≥ median), and overweight status 
(BMI < 25 vs. ≥ 25). We tested potential interactions via adding multiplicative interaction terms 
in the multivariable models. All statistical analyses were performed with SAS software (version 
9.2; SAS Institute Inc.). P < 0.05 was considered statistically significant. 
 
RESULTS 
During 10 years of follow-up, we documented 865 incident GDM pregnancies among 
21,356 eligible singleton pregnancies from 15,225 women. At baseline in 1991, women with 
higher total vitamin D intake were more likely to be white and nonsmokers, more physically 
active, consumed more carbohydrates, protein, dietary fiber, magnesium, potassium, calcium, 
vitamin A, vitamin C, vitamin E, fish, low-fat dairy, nuts, fruits, whole grains, and less alcohol, 
fat, red meat, sugar-sweetened beverages, and had an overall better diet quality (Table 1).  
We observed a significant inverse association between supplemental vitamin D intake 
and the risk of GDM (Table 2). After adjustment for age, parity, non-dietary factors, and dietary 
factors including dietary vitamin D intake, the adjusted RRs (95% CIs) of GDM risk associated 
with supplemental vitamin D intake of 0, 1-399, ≥ 400 IU/d were 1.00 (reference), 0.80 (0.67-
0.96), and 0.71 (0.56-0.90), respectively (P for trend = 0.002). Dietary and total vitamin D 
intakes were also inversely associated with GDM risk, but the associations were not statistically 
significant. The associations of total, dietary, and supplemental vitamin D intake with risk of 












GDM were not significantly modified by other risk factors for GDM, including age, family 
history of diabetes, overall diet quality, physical activity, or overweight status. 
 
DISCUSSION 
In this large prospective cohort study, we found inverse associations of pre-pregnancy 
supplemental vitamin D intake with the risk of GDM. These associations remained statistically 
significant after adjustment for other major risk factors of GDM. Our results also suggested that 
dietary and total vitamin D intakes might be inversely associated with GDM risk, although the 
associations were not statistically significant. 
To our knowledge, the present study is the first attempt to examine the association 
between pre-pregnancy vitamin D intake and GDM risk. Accumulating evidence suggests that 
most women with GDM may have a chronic beta-cell defect and insulin resistance before 
pregnancy.29 Pregnancy itself is a process of progressive insulin resistance that begins near mid-
pregnancy. The metabolic challenges occurring during pregnancy29 serve to unmask a 
predisposition to glucose metabolic disorders in women who have a pre-existed compromised 
capacity to compensate for the progressive insulin resistance of pregnancy.29 Therefore, pre-
pregnancy risk factors implicated in glucose homeostasis may also be physiologically relevant to 
the development of GDM. In a previous study in female guinea pigs, high vitamin D status 
before pregnancy was inversely associated with the development of GDM.15 
Our results were in general consistent with previous cohort studies relating dietary and 
supplemental vitamin D intake to type 2 diabetes risk.30 31 Moreover, we concur with previous 
findings showing the effects vitamin D supplementation on improved glucose metabolism and 
insulin sensitivity in pregnant women.10-12 Several epidemiological studies examining the 












association between maternal circulating vitamin D levels during pregnancy and the risk of 
GDM have yielded equivocal results.32 33 In line with our findings on the association between 
vitamin D intake and GDM risk, a meta-analysis of previous studies has demonstrated a 
significant association of vitamin D insufficiency during pregnancy and increased risk of 
GDM.32 A recent randomized controlled trial also found a lower rate of GDM (13% vs 8%) after 
vitamin D supplementation during early pregnancy, although the difference was not statistically 
significant due to limited sample size.34  
The observed inverse association of pre-pregnancy vitamin D intake with GDM risk is 
biologically supported by the direct and/or indirect effects of vitamin D on insulin secretion and 
insulin sensitivity. Traditionally, vitamin D is thought to act as a facilitator of intestinal calcium 
absorption, which in turn can normalize glucose intolerance.35 However, increasing evidence 
suggests that the effect of vitamin D on beta-cells appears to be direct and independent of 
prevailing plasma calcium concentration.6 36 For instance, inadequate vitamin D impairs insulin 
secretion,7 and the impairment can be ameliorated by vitamin D supplementation.37 Moreover, 
vitamin D receptor and vitamin D-dependent calcium-binding protein are present in human and 
rat pancreatic islet cells.38 Vitamin D may regulate pancreatic beta-cell function and insulin 
secretion through the binding of circulating 1,25-dihydroxyvitamin D to beta-cell vitamin D 
receptor. The binding could regulate the balance between extracellular and intracellular calcium 
pools, which is critical for insulin-mediated intracellular processes in insulin-responsive 
tissues.39 In addition, vitamin D can enhance insulin sensitivity by directly activating 
transcription of the human insulin receptor gene, peroxisome proliferator activator receptor-δ, 
and insulin-mediated glucose transport as well as modulation of cytokine expression and 
activity.36 40 












Our study had several strengths. First, our study has a prospective study design with a 
long duration of follow-up, which establishes the temporal direction of the associations. Second, 
the questionnaires used to assess diet and lifestyle variables in this study have been extensively 
validated.16-21 There were several limitations of this study. First, misclassification of dietary 
vitamin D intake is possible. However, due to the prospective nature of this study, the 
misclassification should be non-differential with regard to incident GDM status; therefore, our 
observed associations may underestimate the true relative risks. Furthermore, the use of 
cumulative averages of dietary intakes for participants with more than one pre-pregnancy FFQ 
reduces random error. Second, our study population consisted mostly of Caucasian American 
women. Thus, the generalizability of the observed associations may be limited to similar 
populations. However, the relative homogeneity of the study population reduces potential 
confounding due to unmeasured socio-economic variability. Because black and Hispanic women 
have higher prevalence of vitamin D insufficiency than white women do,5 future studies across 
races/ethnicities are warranted. Third, the NHSII cohort did not specifically assess diet and 
lifestyle factors during pregnancy. Therefore, we were unable to assess the association of pre-
pregnancy vitamin D intake with GDM risk, independent of vitamin D intake during pregnancy. 
Finally, because of observational nature of this study, a causal relation between pre-pregnancy 
vitamin D intake and GDM risk cannot be inferred. 
In conclusion, pre-pregnancy supplemental vitamin D intake is significantly and 
inversely associated with risk of GDM. Our study indicates potential benefits of increasing 
vitamin D intake from supplements in the prevention of GDM in women of reproductive age. 
Large randomized controlled trials of pre-pregnancy vitamin D supplementation may be 
warranted to confirm our findings. 
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Table 1. Age-standardized characteristics of the study population (n=15,225) in 1991, 
according to categories of total vitamin D intake 
Characteristics 
Total vitamin D intake (IU/d) 
< 200 200-399 400-599 ≥ 600 
Number of participants 2812 4967 3582 3864 
Age, years 31.9 (3.3) 31.9 (3.3) 31.9 (3.2) 32.2 (3.3) 
White, % 91.5 93.2 93.3 94.3 
Family history of 
diabetes, % 11.1 11.5 10.4 10.5 
Nulliparous, % 39.2 36.0 36.9 33.2 
Current smoking, % 14.2 9.5 7.6 5.8 
Alcohol, g/day 3.6 (6.0) 3.3 (5.3) 3.1 (5.0) 2.3 (4.3) 
UVB flux, ×10-4 R-B units 125.2 (24.4) 122.8 (23.4) 123.6 (24.4) 124.4 (24.8) 
BMI, kg/m² 23.4 (4.6) 23.4 (4.3) 23.4 (4.3) 23.6 (4.1) 
Physical activity, MET-
h/wk 20.3 (25.8) 23.3 (29.8) 24.0 (28.5) 24.8 (29.9) 




(560.9) 1730.1 (495.6) 
Carbohydrate, %E 49.7 (8.3) 50.2 (7.0) 51.3 (7.0) 51.3 (6.7) 
Protein, %E 17.9 (3.4) 19.2 (3.1) 19.2 (3.2) 20.2 (3.2) 
Total fat, %E 32.7 (6.0) 31.3 (5.3) 30.3 (5.2) 29.7 (5.0) 
Saturated fat, %E 11.5 (2.6) 11.3 (2.4) 11.0 (2.3) 10.9 (2.2) 
Monounsaturated fat, %E 12.6 (2.5) 11.8 (2.2) 11.4 (2.2) 11.0 (2.2) 
Polyunsaturated fat, %E 5.7 (1.4) 5.5 (1.3) 5.3 (1.3) 5.2 (1.2) 
Trans fat, %E 1.8 (0.7) 1.6 (0.6) 1.5 (0.6) 1.4 (0.5) 
Cholesterol, mg/d* 234.0 (69.2) 239.1 (62.2) 236.6 (62.8) 238.1 (64.2) 












Glycemic Index* 55.3 (3.2) 54.0 (3.0) 53.7 (3.2) 53.2 (3.3) 
Glycemic Load* 124.7 (23.7) 122.4 (20.1) 123.9 (20.2) 123.8 (19.7) 
Total fiber, g/d* 17.3 (5.5) 18.0 (5.0) 18.3 (5.4) 18.4 (5.9) 
Magnesium, mg/d* 265.9 (57.7) 302.0 (53.7) 332.0 (67.3) 365.8 (78.5) 
Heme iron, mg/d* 1.1 (0.4) 1.1 (0.4) 1.0 (0.4) 1.0 (0.4) 




(495.9) 3023.3 (483.5) 
Calcium, mg/d* 703.0 (217.8) 969.3 (285.6) 1148.1 (363.3) 1397.8 (465.4) 





Vitamin C, mg/d* 167.0 (195.9) 197.5 (218.7) 267.8 (257.7) 349.5 (352.1) 
Vitamin E, mg/d* 12.6 (36.5) 15.2 (37.1) 22.5 (42.3) 30.9 (56.1) 
Red meat, servings/d 0.9 (0.6) 0.8 (0.6) 0.8 (0.5) 0.6 (0.4) 
Poultry, servings/d 0.4 (0.3) 0.5 (0.3) 0.5 (0.3) 0.4 (0.3) 
Fish, servings/d 0.1 (0.1) 0.2 (0.2) 0.3 (0.2) 0.3 (0.3) 
Eggs, servings/d 0.2 (0.2) 0.2 (0.2) 0.2 (0.2) 0.2 (0.2) 
Low-fat dairy, servings/d 0.6 (0.5) 1.5 (1.0) 1.8 (1.3) 2.2 (1.4) 
High-fat dairy, servings/d 1.0 (0.9) 1.1 (1.0) 1.1 (1.0) 0.9 (0.8) 
Nuts, servings/d 0.2 (0.3) 0.3 (0.3) 0.3 (0.4) 0.2 (0.3) 
Legumes, servings/d 0.3 (0.3) 0.4 (0.3) 0.4 (0.4) 0.3 (0.3) 
Vegetables, servings/d 3.0 (2.1) 3.3 (2.0) 3.4 (2.0) 3.0 (1.8) 
Fruits, servings/d 1.0 (0.9) 1.2 (1.0) 1.4 (1.0) 1.3 (1.0) 
Whole grains, servings/d 0.9 (1.0) 1.1 (1.0) 1.3 (1.1) 1.1 (1.0) 
SSBs, servings/d 0.8 (1.1) 0.5 (0.8) 0.6 (0.9) 0.4 (0.6) 
AHEI score 40.3 (10.3) 43.6 (10.2) 43.9 (10.5) 45.2 (10.0) 
Values are means (SD) unless otherwise specified. 












* Value is energy-adjusted. 
%E, % of energy; AHEI indicates alternate healthy eating index; BMI, body mass index; IU, 
international unit; MET, metabolic equivalent; SSBs, sugar-sweetened beverages; UVB, 
ultraviolet B. 
All comparisons were significant across categories, except family history of diabetes and BMI.












Table 2. Risk of gestational diabetes in association with pre-pregnancy vitamin D intake 
 Total vitamin D intake (IU/d) P for 
trend  < 200 200-399 400-599 ≥ 600 
GDM/pregnancies 174/3,618 307/6,948 188/5,459 196/5,331  
Model 1 1.00 0.90 (0.75, 1.08) 0.69 (0.57, 0.85) 0.76 (0.62, 0.93) 0.002 
Model 2 1.00 0.98 (0.82, 1.17) 0.78 (0.64, 0.95) 0.85 (0.70, 1.04) 0.03 
Model 3 1.00 0.95 (0.76, 1.19) 0.77 (0.58, 1.03) 0.86 (0.61, 1.20) 0.31 
 
Dietary vitamin D intake (IU/d)1 P for 
trend < 200 200-399 ≥ 400  
GDM/pregnancies 163/3,224 195/4,381 37/1,016   
Model 1 1.00 0.88 (0.72, 1.08) 0.72 (0.51, 1.03)  0.05 
Model 2 1.00 0.97 (0.79, 1.19) 0.83 (0.58, 1.17)  0.34 
Model 3 1.00 0.89 (0.69, 1.16) 0.78 (0.49, 1.26)  0.28 
 
Supplemental vitamin D intake (IU/d)2 P for 
trend 0 1-399 ≥ 400  
GDM/pregnancies 395/8,621 280/7,174 190/5,561   
Model 1 1.00 0.79 (0.68, 0.92) 0.76 (0.64, 0.90)  < 0.001 
Model 2 1.00 0.83 (0.71, 0.96) 0.78 (0.66, 0.92)  0.002 
Model 32 1.00 0.80 (0.67, 0.96) 0.71 (0.56, 0.90)  0.002 
 
Model 1: Adjusted for age (months).  
Model 2: Model 1 + additionally adjusted for parity (0, 1, 2, 3+), race/ethnicity (Caucasian, 
African-American, Hispanic, Asian, others), family history of diabetes (yes, no), cigarette 












smoking (never, past, current), alcohol intake (0, 0.1-4.9, 5.0-9.9, ≥ 10.0 g/d), physical activity 
(quartiles), estimated UVB flux (quartiles), and BMI (nine categories, < 21, 21-22.9, 23.0-24.9, 
25.0-26.9, 27.0-28.9, 29.0-30.9, 31.0 -32.9, 33.0-34.9 and ≥ 35.0 kg/m2).  
Model 3: Model 2 + additionally adjusted for total energy intake (quartiles), and intakes of 
saturated fat (quartiles), monounsaturated fat (quartiles), polyunsaturated fat (quartiles), trans fat 
(quartiles), dietary cholesterol (quartiles), glycemic load (quartiles), dietary fiber (quartiles), 
magnesium (quartiles), calcium (quartiles), and vitamin A (quartiles).  
 
1 The analytic population consisted of women who did not consume specific vitamin D 
supplements or vitamin D-containing multivitamins at baseline and during follow-up. 
2 Additionally adjusted for dietary vitamin D intake in the entire analysis of supplemental 
vitamin D intake. 
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